Study Name Principal Investigator
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(HLA-G) To Develop and Optimize Innovative Methods and Therapies that Prevent Rejection and Prolong Transplant Survival in Patients Mulloy, Laura
(In vitro D-dimer) The Diagnostic Utility of the in-vitro Provoked D dimer test in patients with suspected thromboembolism, either pulmonary embolism (PE) or deep venous thrombosis (DVT) or both Robinson, Vincent
(KEYNOTE-921) A Phase 3, Randomized, Double-blind Study of Pembrolizumab (MK-3475) Plus Docetaxel Plus Prednisone versus Placebo Plus Docetaxel Plus Prednisone in Participants with Chemotherapy-naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC) who have Progressed on a Next Generation Hormonal Agent (NHA) Parikh, Jigarkumar
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TWO FIXED DOSES OF TAVAPADON IN EARLY PARKINSON’S DISEASE (TEMPO-1 TRIAL) Morgan, John
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAVAPADON AS ADJUNCTIVE THERAPY FOR PARKINSON’S DISEASE IN LEVODOPA-TREATED ADULTS WITH MOTOR FLUCTUATIONS (TEMPO-3 TRIAL) Morgan, John
A phase Ib /II trial of pembrolizumab and idelalisib in patients with non-small cell lung cancer (NSCLC) who have failed immune checkpoint inhibitor Hao, Zhonglin
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls Morgan, John
A011502: A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer: the ABC trial Ghamande, Sharad
An Objective Tool to Aid Diagnosis of PTSD and Evaluate Treatment outcome Vazdarjanova, Almira
CC-16047: A Phase I/II Trial Of Pembrolizumab (MK-3475) And Poly-ICLC (Hiltonol®) In Patients With Metastatic Mismatch Repair-Proficient (MRP) Colon Cancer Nayak-Kapoor, Asha
CDX1140-01: A Phase 1 Study of CDX-1140, a Fully Human Agonist anti-CD40 Monoclonal Antibody, as Monotherapy or in Combination in Patients with Advanced Malignancies Kota, Vamsi
EA1131 A Randomized Phase III Post Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy Ghamande, Sharad
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease Morgan, John
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications Morgan, John
PNH Registry Kutlar, Abdullah
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Kota, Vamsi
Psychological Flexibility and Changes in Functioning in an Acceptance and Commitment Therapy Group for Stage 2 DBT Patients House, Amy
Rostock International Parkinson’s Disease Study - An international, multicentre, epidemiological observational study Morgan, John
RESEARCH. INNOVATION. DISCOVERY.
Augusta University
Research
AU Health
Stay Informed
Get updates on new trials and more
(706)721-6582 © Augusta University 1120 15th Street Augusta, GA 30912